A 22-year-old transgender man presents requesting informatio…

A 22-year-old transgender man presents requesting information about testosterone therapy. The NP discusses the therapy with the patient who demonstrates clear understanding of the risks, benefits, and alternatives, and expresses consistent goals aligned with masculinization. The NP gets the patient’s verbal informed consent for a referral. By getting consent, the NP implements the ethic of:

Ali has been receiving cisplatin 75 mg/m2/day on day 1 in co…

Ali has been receiving cisplatin 75 mg/m2/day on day 1 in combination with paclitaxel 175 mg/m2/day on day 1 for advanced ovarian cancer every 3 weeks (plan for 6 cycles). Recently Ali has been experiencing nausea on days 2 and 3 despite the current preventative antiemetic regimen. Which breakthrough medication would you recommend adding to Ali’s current regimen (you can assume dose and dosing intervals are correct)? Current regimen: Fosaprepitant 150 mg IV on day 1 Palonosetron 0.25 mg IV on day 1 Olanzapine 5 mg PO on day 1-4 Dexamethasone 12 mg PO day 1, 8 mg PO days 2-4